Cargando…

Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies

The outbreak of monkeypox, coupled with the onslaught of the COVID-19 pandemic is a critical communicable disease. This study aimed to systematically identify and review research done on preclinical studies focusing on the potential monkeypox treatment and immunization. The presented juxtaposition o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sudarmaji, Nurizzati, Kifli, Nurolaini, Hermansyah, Andi, Yeoh, Siang Fei, Goh, Bey-Hing, Ming, Long Chiau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699130/
https://www.ncbi.nlm.nih.gov/pubmed/36423105
http://dx.doi.org/10.3390/v14112496
_version_ 1784838995623018496
author Sudarmaji, Nurizzati
Kifli, Nurolaini
Hermansyah, Andi
Yeoh, Siang Fei
Goh, Bey-Hing
Ming, Long Chiau
author_facet Sudarmaji, Nurizzati
Kifli, Nurolaini
Hermansyah, Andi
Yeoh, Siang Fei
Goh, Bey-Hing
Ming, Long Chiau
author_sort Sudarmaji, Nurizzati
collection PubMed
description The outbreak of monkeypox, coupled with the onslaught of the COVID-19 pandemic is a critical communicable disease. This study aimed to systematically identify and review research done on preclinical studies focusing on the potential monkeypox treatment and immunization. The presented juxtaposition of efficacy of potential treatments and vaccination that had been tested in preclinical trials could serve as a useful primer of monkeypox virus. The literature identified using key terms such as monkeypox virus or management or vaccine stringed using Boolean operators was systematically reviewed. Pubmed, SCOPUS, Cochrane, and preprint databases were used, and screening was performed in accordance with PRISMA guidelines. A total of 467 results from registered databases and 116 from grey literature databases were screened. Of these results, 72 studies from registered databases and three grey literature studies underwent full-text screening for eligibility. In this systematic review, a total of 27 articles were eligible according to the inclusion criteria and were used. Tecovirimat, known as TPOXX or ST-246, is an antiviral drug indicated for smallpox infection whereas brincidofovir inhibits the viral DNA polymerase after incorporation into viral DNA. The ability of tecovirimat in providing protection to poxvirus-challenged animals from death had been demonstrated in a number of animal studies. Non-inferior with regard to immunogenicity was reported for the live smallpox/monkeypox vaccine compared with a single dose of a licensed live smallpox vaccine. The trial involving the live vaccine showed a geometric mean titre of vaccinia-neutralizing antibodies post two weeks of the second dose of the live smallpox/monkeypox vaccine. Of note, up to the third generation of smallpox vaccines—particularly JYNNEOS and Lc16m8—have been developed as preventive measures for MPXV infection and these vaccines had been demonstrated to have improved safety compared to the earlier generations.
format Online
Article
Text
id pubmed-9699130
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96991302022-11-26 Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies Sudarmaji, Nurizzati Kifli, Nurolaini Hermansyah, Andi Yeoh, Siang Fei Goh, Bey-Hing Ming, Long Chiau Viruses Systematic Review The outbreak of monkeypox, coupled with the onslaught of the COVID-19 pandemic is a critical communicable disease. This study aimed to systematically identify and review research done on preclinical studies focusing on the potential monkeypox treatment and immunization. The presented juxtaposition of efficacy of potential treatments and vaccination that had been tested in preclinical trials could serve as a useful primer of monkeypox virus. The literature identified using key terms such as monkeypox virus or management or vaccine stringed using Boolean operators was systematically reviewed. Pubmed, SCOPUS, Cochrane, and preprint databases were used, and screening was performed in accordance with PRISMA guidelines. A total of 467 results from registered databases and 116 from grey literature databases were screened. Of these results, 72 studies from registered databases and three grey literature studies underwent full-text screening for eligibility. In this systematic review, a total of 27 articles were eligible according to the inclusion criteria and were used. Tecovirimat, known as TPOXX or ST-246, is an antiviral drug indicated for smallpox infection whereas brincidofovir inhibits the viral DNA polymerase after incorporation into viral DNA. The ability of tecovirimat in providing protection to poxvirus-challenged animals from death had been demonstrated in a number of animal studies. Non-inferior with regard to immunogenicity was reported for the live smallpox/monkeypox vaccine compared with a single dose of a licensed live smallpox vaccine. The trial involving the live vaccine showed a geometric mean titre of vaccinia-neutralizing antibodies post two weeks of the second dose of the live smallpox/monkeypox vaccine. Of note, up to the third generation of smallpox vaccines—particularly JYNNEOS and Lc16m8—have been developed as preventive measures for MPXV infection and these vaccines had been demonstrated to have improved safety compared to the earlier generations. MDPI 2022-11-11 /pmc/articles/PMC9699130/ /pubmed/36423105 http://dx.doi.org/10.3390/v14112496 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Sudarmaji, Nurizzati
Kifli, Nurolaini
Hermansyah, Andi
Yeoh, Siang Fei
Goh, Bey-Hing
Ming, Long Chiau
Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies
title Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies
title_full Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies
title_fullStr Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies
title_full_unstemmed Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies
title_short Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies
title_sort prevention and treatment of monkeypox: a systematic review of preclinical studies
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699130/
https://www.ncbi.nlm.nih.gov/pubmed/36423105
http://dx.doi.org/10.3390/v14112496
work_keys_str_mv AT sudarmajinurizzati preventionandtreatmentofmonkeypoxasystematicreviewofpreclinicalstudies
AT kiflinurolaini preventionandtreatmentofmonkeypoxasystematicreviewofpreclinicalstudies
AT hermansyahandi preventionandtreatmentofmonkeypoxasystematicreviewofpreclinicalstudies
AT yeohsiangfei preventionandtreatmentofmonkeypoxasystematicreviewofpreclinicalstudies
AT gohbeyhing preventionandtreatmentofmonkeypoxasystematicreviewofpreclinicalstudies
AT minglongchiau preventionandtreatmentofmonkeypoxasystematicreviewofpreclinicalstudies